Close Menu

NEW YORK (GenomeWeb News) – Cepheid reported after the market closed on Thursday that its third quarter revenues increased 24 percent year over year.

The Sunnyvale, Calif.-based molecular diagnostics firm reported total revenues of $100.1 million for the three months ended Sept. 30, compared to $80.5 million for the third quarter of 2012. It exceeded the consensus analysts' estimate of $93.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.